Liver Cirrhosis: all 1,668 studies
Page 10 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver CirrhosisTerminatedNCT04140591Phase 2/3
- Role of MRI in Detection of Minimal Hepatic EncephalopathyStatus unknownNCT04131205
- Gastric Slow Wave and Autonomic Nervous Function in Cirrhotic Patients With Esophageal Varices After Ligation-A Clinical ResearchCompletedNCT04125875
- Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter SurveyCompletedNCT04121520
- MERTK Signalling in Monocytes/Macrophages in Patients With Liver DiseaseCompletedNCT04116242
- The EUS ShearWave Elastography Liver Fibrosis StudyCompletedNCT04115046
- Simplified Monitoring Myanmar SM2 StudyCompletedNCT04113629Not applicable
- Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver TransplantationCompletedNCT04113317Phase 3
- A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesTerminatedNCT04112199Phase 2
- Heparin Like Effect in Acute Variceal BleedingStatus unknownNCT04111120
- Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume ParacentesisWithdrawnNCT04109144Phase 2
- Pirfenidone and Advanced Liver Fibrosis.CompletedNCT04099407Phase 2
- "To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR ShuntStatus unknownNCT04089878Not applicable
- Rifamycin in Minimal Hepatic EncephalopathyCompletedNCT04082780Phase 2
- Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular CarcinomaStatus unknownNCT04076631
- Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive ProceduresCompletedNCT04076605
- Characterization of the Nutritional Status in the Patient With Liver CirrhosisCompletedNCT04073693Not applicable
- Statins for Prevention of Disease Progression and Hospitalization in Liver CirrhosisTerminatedNCT04072601Phase 4
- Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With AscitesStatus unknownNCT04058613Not applicable
- A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and MalnutritionStatus unknownNCT04057326Not applicable
- Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With CirrhosisWithdrawnNCT04055389Phase 1
- Sorafenib PK in Patients With Advanced HCC and Child-Pugh BTerminatedNCT04051853Phase 2
- Plasma Exchange in Acute on Chronic Liver FailureStatus unknownNCT04051437Phase 3
- Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)CompletedNCT04047160Phase 1
- TIPS Plus Transvenous Obliteration for Gastric VaricesCompletedNCT04044248
- Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.Status unknownNCT04013074Not applicable
- EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRIStatus unknownNCT04012021Not applicable
- Evaluation of Accuvein in Cirrhotics PatientsStatus unknownNCT03996135Not applicable
- Monocytic Expression of HLA-DR After Liver TransplantationCompletedNCT03995537
- Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.Status unknownNCT03995251Not applicable
- Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)Status unknownNCT03990753
- Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver CirrhosisStatus unknownNCT03989973
- Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic TargetsCompletedNCT03979417
- ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS PlacementActive, not recruitingNCT03973372
- Give a MANNA a Fish, Teach a MANNA to FishWithdrawnNCT03969199Not applicable
- Telehealth Intervention in CirrhoticsCompletedNCT03969186Not applicable
- Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis PatientsStatus unknownNCT03969017Phase 2
- Safety and Efficacy of SHED for Decompensated Liver CirrhosisStatus unknownNCT03957655Early Phase 1
- Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03957629Not applicable
- Mesenchymal Stem Cells Treatment for Decompensated Liver CirrhosisStatus unknownNCT03945487Phase 2
- Endoscopic Variceal Ligation in ChildrenCompletedNCT03943784
- Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)CompletedNCT03941405Phase 2
- Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)CompletedNCT03932552Not applicable
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
- Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosisStatus unknownNCT03919565Not applicable
- Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological CharacteristicsCompletedNCT03919032
- GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCTStatus unknownNCT03911037Phase 2/3
- Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral AgentsCompletedNCT03908294
- Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral DrugsStatus unknownNCT03897608
- Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave ElastographyTerminatedNCT03896607
- Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
- Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled TrialStatus unknownNCT03892070Not applicable
- Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting AntiviralsCompletedNCT03884062
- Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)TerminatedNCT03878563
- Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular CarcinomaActive, not recruitingNCT03878550
- Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese PatientsCompletedNCT03872024Not applicable
- Indirect Calorimeter Based Study in Patients With Liver CirrhosisCompletedNCT03871894Not applicable
- Preoperative Portal and Splanchnic Flow Measurement Using MRIStatus unknownNCT03868397Not applicable
- The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled TrialCompletedNCT03864276Not applicable
- Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaActive, not recruitingNCT03863730Not applicable
- Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated CirrhosisCompletedNCT03855956Not applicable
- Antibiotic-resistant Bacterial Infection of Hepatic PatientsStatus unknownNCT03855709
- Probiotics in the Prevention of Hepatocellular Carcinoma in CirrhosisStatus unknownNCT03853928Not applicable
- Is There an Association Between Chronic Pancreatitis and Pulmonary FunctionCompletedNCT03850977
- OCR002-SP103 - Oral Immediate Release StudyCompletedNCT03846843Phase 1
- Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal HemorrhageCompletedNCT03846180
- Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisStatus unknownNCT03842748
- Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LCStatus unknownNCT03838250Phase 1
- Microvesicles and Monocytes to Predict Mortality of Patients with CirrhosisCompletedNCT03837444
- Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.Status unknownNCT03837145
- To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.Status unknownNCT03827681Not applicable
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisTerminatedNCT03827200Phase 2
- HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)CompletedNCT03804593
- Validation of Point of Care Liver Function TestsTerminatedNCT03800069
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)Status unknownNCT03798119Phase 4
- Population-based Study in Screening for Liver FibrosisCompletedNCT03789825
- Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF DevelopmentCompletedNCT03780673Phase 2/3
- Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)Status unknownNCT03778775
- Beta-blockers for Oesophageal VaricesStatus unknownNCT03776955Phase 4
- N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO TrialCompletedNCT03759158Not applicable
- Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) CirrhoticsCompletedNCT03753438
- Detachable String Magnetically Controlled Capsule Endoscopy for Detecting High-risk Varices in Compensated CirrhosisStatus unknownNCT03749954
- Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With CirrhosisCompletedNCT03748563Not applicable
- Carvedilol for Prevention of Esophageal Varices ProgressionStatus unknownNCT03736265Not applicable
- Abbreviated MRI for HCC SurveillanceActive, not recruitingNCT03731923Not applicable
- Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric VaricesStatus unknownNCT03729921Not applicable
- A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsCompletedNCT03726827
- Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLDStatus unknownNCT03725631Not applicable
- Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant SurvivalCompletedNCT03723317
- Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated CirrhosisCompletedNCT03695705Phase 3
- Clinical Trial Multi-analyte Blood TestActive, not recruitingNCT03694600
- HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal BleedingStatus unknownNCT03687216Not applicable
- Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Liver CirrhosisStatus unknownNCT03675633
- Technical Validation of MR Biomarkers of Obesity-Associated NAFLDCompletedNCT03674528
- The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function ImpairmentStatus unknownNCT03673215Early Phase 1
- ObeSity Related Colorectal Adenoma RiskCompletedNCT03663062
- Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVRCompletedNCT03659058Not applicable
- Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal EndoscopyTerminatedNCT03658551
- Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child CActive, not recruitingNCT03633279Phase 3
- Assessment of Sarcopenia in Patients With Liver Cirrhosis and Its Prognostic Value in Liver Transplant CandidatesStatus unknownNCT03629444